ABN Newswire is a business newswire and press release distribution service for listed companies on stock exchanges globally. ABN Newswire distributes company announcements to the professional platforms, finance portals and syndicates important corporate news to a wide variety of news aggregators and financial news systems.
Biotec Pharmacon ASA (OSL:BIOTEC) Sven Rohmann, Vice President Business Development at Biotec Pharmacon, has today bought 7,000 shares in the company at a price of 11.20 NOK per share. After this transaction Sven Rohmann owns 31,000 shares in Biotec Pharmacon.
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.